- Home
- Publications
- Publication Search
- Publication Details
Title
Developing therapeutic vaccines against Alzheimer’s disease
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume -, Issue -, Pages 1-15
Publisher
Informa UK Limited
Online
2015-11-18
DOI
10.1586/14760584.2016.1121815
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
- (2016) Eric R. Siemers et al. Alzheimers & Dementia
- Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes
- (2015) Lauren Walker et al. ACTA NEUROPATHOLOGICA
- PART, a distinct tauopathy, different from classical sporadic Alzheimer disease
- (2015) Kurt A. Jellinger et al. ACTA NEUROPATHOLOGICA
- 2015 Alzheimer's disease facts and figures
- (2015) Alzheimers & Dementia
- Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
- (2015) Celeste M. Karch et al. BIOLOGICAL PSYCHIATRY
- Development of a high affinity Affibody-derived protein against amyloid β-peptide for future Alzheimer's disease therapy
- (2015) Erwin De Genst et al. Biotechnology Journal
- A truncated and dimeric format of an Affibody library on bacteria enables FACS-mediated isolation of amyloid-beta aggregation inhibitors with subnanomolar affinity
- (2015) Hanna Lindberg et al. Biotechnology Journal
- Amyloid Pathology, Cognitive Impairment, and Alzheimer Disease Risk—Reply
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy
- (2015) Zane Jaunmuktane et al. NATURE
- The case for rejecting the amyloid cascade hypothesis
- (2015) Karl Herrup NATURE NEUROSCIENCE
- Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
- (2015) Erik S Musiek et al. NATURE NEUROSCIENCE
- Clearance systems in the brain—implications for Alzheimer disease
- (2015) Jenna M. Tarasoff-Conway et al. Nature Reviews Neurology
- Amyloid-β11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
- (2015) Enchi Liu et al. NEUROLOGY
- Immunotherapeutic Approaches for Alzheimer’s Disease
- (2015) Thomas Wisniewski et al. NEURON
- Tau immunotherapy for Alzheimer's disease
- (2015) Jan Torleif Pedersen et al. TRENDS IN MOLECULAR MEDICINE
- Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease
- (2015) Martin R Farlow et al. Alzheimers Research & Therapy
- Interaction between therapeutic interventions for Alzheimer’s disease and physiological Aβ clearance mechanisms
- (2015) Christopher D. Morrone et al. Frontiers in Aging Neuroscience
- Development of a high affinity Affibody-derived protein against amyloid β-peptide for future Alzheimer's disease therapy
- (2015) Erwin De Genst et al. Biotechnology Journal
- A truncated and dimeric format of an Affibody library on bacteria enables FACS-mediated isolation of amyloid-beta aggregation inhibitors with subnanomolar affinity
- (2015) Hanna Lindberg et al. Biotechnology Journal
- Primary age-related tauopathy (PART): a common pathology associated with human aging
- (2014) John F. Crary et al. ACTA NEUROPATHOLOGICA
- ACTIVE Aβ IMMUNOTHERAPY CAD106 PHASE II DOSE-ADJUVANT FINDING STUDY: SAFETY AND CNS BIOMARKERS
- (2014) Ana Graf et al. Alzheimers & Dementia
- Immunotherapy for Alzheimer's disease
- (2014) Thomas Wisniewski et al. BIOCHEMICAL PHARMACOLOGY
- Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis
- (2014) May A Beydoun et al. BMC PUBLIC HEALTH
- Human CNS immune senescence and neurodegeneration
- (2014) Wolfgang J Streit et al. CURRENT OPINION IN IMMUNOLOGY
- Tau-Based Therapeutic Approaches for Alzheimer's Disease - A Mini-Review
- (2014) Allal Boutajangout et al. GERONTOLOGY
- ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?
- (2014) Takahisa Kanekiyo et al. NEURON
- Alzheimer’s Disease Genetics: From the Bench to the Clinic
- (2014) Celeste M. Karch et al. NEURON
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
- (2014) Eva Kontsekova et al. Alzheimers Research & Therapy
- Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: relevance to sporadic tauopathies
- (2014) Simon Dujardin et al. Acta Neuropathologica Communications
- Innate immunity stimulation via TLR9 in a non-human primate model of sporadic cerebral amyloid angiopathy
- (2013) Henrieta Scholtzova et al. Alzheimers & Dementia
- Pyroglutamate-3 Amyloid-β Deposition in the Brains of Humans, Non-Human Primates, Canines, and Alzheimer Disease–Like Transgenic Mouse Models
- (2013) Jeffrey L. Frost et al. AMERICAN JOURNAL OF PATHOLOGY
- TREM2 and the neuroimmunology of Alzheimer's disease
- (2013) Suzanne E. Hickman et al. BIOCHEMICAL PHARMACOLOGY
- Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
- (2013) Bin Zhang et al. CELL
- Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer’s disease pathology in TgSwDI and 3xTg mouse models
- (2013) Fernando Goñi et al. Journal of Neuroinflammation
- How Do Immune Cells Support and Shape the Brain in Health, Disease, and Aging?
- (2013) M. Schwartz et al. JOURNAL OF NEUROSCIENCE
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Immunotherapy for Alzheimer’s disease: hoops and hurdles
- (2013) Cynthia A Lemere Molecular Neurodegeneration
- Immunotherapy for Alzheimer’s Disease
- (2013) Martin R. Farlow et al. NEUROLOGIC CLINICS
- Innate Immunity in the CNS: Redefining the Relationship between the CNS and Its Environment
- (2013) Antoine Lampron et al. NEURON
- Intercellular transfer of tau aggregates and spreading of tau pathology: Implications for therapeutic strategies
- (2013) Florence Clavaguera et al. NEUROPHARMACOLOGY
- Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
- (2013) Clara Theunis et al. PLoS One
- Prions, prionoids and pathogenic proteins in Alzheimer disease
- (2013) Karen H. Ashe et al. Prion
- Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology
- (2013) J.-P. Michaud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alzheimer Disease in 2020
- (2013) D. M. Holtzman et al. Cold Spring Harbor Perspectives in Medicine
- Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease
- (2012) Martin Farlow et al. Alzheimers & Dementia
- Therapeutic strategies for tau mediated neurodegeneration
- (2012) Y. Yoshiyama et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A Binding Properties Promotes Neuroprotection and Glial Engulfment of A
- (2012) O. Adolfsson et al. JOURNAL OF NEUROSCIENCE
- Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
- (2012) Reisa Sperling et al. LANCET NEUROLOGY
- Active immunotherapy for Alzheimer's disease
- (2012) Thomas Wisniewski LANCET NEUROLOGY
- Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
- (2012) Bengt Winblad et al. LANCET NEUROLOGY
- A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice
- (2012) Ronald B. DeMattos et al. NEURON
- Review: Experimental manipulations of microglia in mouse models of Alzheimer's pathology: activation reduces amyloid but hastens tau pathology
- (2012) D. C. Lee et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Trans-Synaptic Spread of Tau Pathology In Vivo
- (2012) Li Liu et al. PLoS One
- Hyperphosphorylated tau in young and middle-aged subjects
- (2011) Adila Elobeid et al. ACTA NEUROPATHOLOGICA
- Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders
- (2011) Mathias Jucker et al. ANNALS OF NEUROLOGY
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- Autosomal Recessive Causes Likely in Early-Onset Alzheimer Disease
- (2011) Thomas S. Wingo ARCHIVES OF NEUROLOGY
- Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models
- (2011) Xiyun Chai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding Diseases
- (2011) David T. Hickman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
- (2011) Allal Boutajangout et al. JOURNAL OF NEUROCHEMISTRY
- The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
- (2011) C. Wiessner et al. JOURNAL OF NEUROSCIENCE
- Alzheimer's Disease Brain-Derived Amyloid- -Mediated Inhibition of LTP In Vivo Is Prevented by Immunotargeting Cellular Prion Protein
- (2011) A. E. Barry et al. JOURNAL OF NEUROSCIENCE
- The pathological process underlying Alzheimer’s disease in individuals under thirty
- (2010) Heiko Braak et al. ACTA NEUROPATHOLOGICA
- Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer's disease model mouse
- (2010) Erika Chung et al. BMC NEUROSCIENCE
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
- (2010) Stephanie J. Soscia et al. PLoS One
- Immunomodulation Targeting Abnormal Protein Conformation Reduces Pathology in a Mouse Model of Alzheimer's Disease
- (2010) Fernando Goñi et al. PLoS One
- Minocycline as a potential therapeutic agent in neurodegenerative disorders characterized by protein misfolding
- (2010) Wendy Noble et al. Prion
- Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
- (2009) Jörg Vollmer et al. ADVANCED DRUG DELIVERY REVIEWS
- Immunotherapy targeting abnormal protein conformation
- (2009) Thomas Wisniewski et al. Alzheimers & Dementia
- Prefilament tau species as potential targets for immunotherapy for Alzheimer disease and related disorders
- (2009) Rakez Kayed et al. CURRENT OPINION IN IMMUNOLOGY
- Picomolar Amyloid- Positively Modulates Synaptic Plasticity and Memory in Hippocampus
- (2009) D. Puzzo et al. JOURNAL OF NEUROSCIENCE
- CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar A -Stimulated Microglial Activation
- (2009) E. G. Reed-Geaghan et al. JOURNAL OF NEUROSCIENCE
- -Amyloid Monomers Are Neuroprotective
- (2009) M. L. Giuffrida et al. JOURNAL OF NEUROSCIENCE
- Induction of Toll-Like Receptor 9 Signaling as a Method for Ameliorating Alzheimer's Disease-Related Pathology
- (2009) H. Scholtzova et al. JOURNAL OF NEUROSCIENCE
- Development of AFFITOPE vaccines for Alzheimer’s disease (AD) — From concept to clinical testing
- (2009) A. Schneeberger et al. Journal of Nutrition Health & Aging
- Transmission and spreading of tauopathy in transgenic mouse brain
- (2009) Florence Clavaguera et al. NATURE CELL BIOLOGY
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer' Disease: The Role of the Immune System in Clearance of Aβ from the Brain
- (2008) Delphine Boche et al. BRAIN PATHOLOGY
- Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease
- (2008) Jing-Ji Jin et al. Journal of Neuroinflammation
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Progress in the Active Immunotherapeutic Approach to Alzheimer’s Disease: Clinical Investigations into AN1792-Associated Meningoencephalitis
- (2008) Michael Pride et al. Neurodegenerative Diseases
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now